BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fowler H, Belot A, Ellis L, Maringe C, Luque-Fernandez MA, Njagi EN, Navani N, Sarfati D, Rachet B. Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers. BMC Cancer 2020;20:2. [PMID: 31987032 DOI: 10.1186/s12885-019-6472-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Boakye D, Nagrini R, Ahrens W, Haug U, Günther K. The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis. Ther Adv Med Oncol 2021;13:1758835920986520. [PMID: 33613694 DOI: 10.1177/1758835920986520] [Reference Citation Analysis]
2 Zhang N, Wang Y, Yu H, Zhang Y, Xiang F, Jiang H, Zheng Y, Xiong Y, Wang Z, Chen Y, Jiang Q, Shao Y, Zhou Y. Distance to highway and factory density related to lung cancer death and associated spatial heterogeneity in effects in Jiading District, Shanghai. Environ Sci Pollut Res Int 2021. [PMID: 34312750 DOI: 10.1007/s11356-021-15438-5] [Reference Citation Analysis]
3 Exarchakou A, Kipourou DK, Belot A, Rachet B. Socio-economic inequalities in cancer survival: how do they translate into Number of Life-Years Lost? Br J Cancer 2022. [PMID: 35149855 DOI: 10.1038/s41416-022-01720-x] [Reference Citation Analysis]
4 Sionakidis A, McCallum L, Padmanabhan S. Unravelling the tangled web of hypertension and cancer. Clin Sci (Lond) 2021;135:1609-25. [PMID: 34240734 DOI: 10.1042/CS20200307] [Reference Citation Analysis]
5 Pilleron S, Maringe C, Charvat H, Atkinson J, Morris E, Sarfati D. Age disparities in lung cancer survival in New Zealand: The role of patient and clinical factors. Lung Cancer 2021;157:92-9. [PMID: 34006378 DOI: 10.1016/j.lungcan.2021.05.015] [Reference Citation Analysis]
6 Rustamaji HC, Suharini YS, Permana AA, Kusuma WA, Nurdiati S, Batubara I, Djatna T. A network analysis to identify lung cancer comorbid diseases. Appl Netw Sci 2022;7. [DOI: 10.1007/s41109-022-00466-y] [Reference Citation Analysis]
7 Shin J, Harris C, Oppegaard K, Kober KM, Paul SM, Cooper BA, Hammer M, Conley Y, Levine JD, Miaskowski C. Worst Pain Severity Profiles of Oncology Patients Are Associated With Significant Stress and Multiple Co-Occurring Symptoms. J Pain 2021:S1526-5900(21)00289-3. [PMID: 34298161 DOI: 10.1016/j.jpain.2021.07.001] [Reference Citation Analysis]
8 Edbrooke L, Denehy L, Patrick C, Tuffaha H. Cost-effectiveness analysis of home-based rehabilitation compared to usual care for people with inoperable lung cancer. Eur J Cancer Care (Engl) 2021. [PMID: 34396615 DOI: 10.1111/ecc.13501] [Reference Citation Analysis]
9 Schofield J, Steven D, Foster R, Matheson C, Baldacchino A, McAuley A, Parkes T. Quantifying prescribed high dose opioids in the community and risk of overdose. BMC Public Health 2021;21:1174. [PMID: 34162361 DOI: 10.1186/s12889-021-11162-4] [Reference Citation Analysis]
10 Ward T, Medina-Lara A, Mujica-Mota RE, Spencer AE. Accounting for Heterogeneity in Resource Allocation Decisions: Methods and Practice in UK Cancer Technology Appraisals. Value Health 2021;24:995-1008. [PMID: 34243843 DOI: 10.1016/j.jval.2020.12.022] [Reference Citation Analysis]
11 Hynes C, Hodges VJ, Wyld L, Mitchell C. Cancer treatment decisions for people living with dementia: Experiences of family carers, a qualitative interview study. Health Expect 2022. [PMID: 35297137 DOI: 10.1111/hex.13466] [Reference Citation Analysis]
12 Arsanjani R, Khera N. Financial Toxicity in Cancer and Cardiovascular Disease: A Threat to Access and Quality of Care. JACC CardioOncol 2021;3:247-9. [PMID: 34396330 DOI: 10.1016/j.jaccao.2021.04.002] [Reference Citation Analysis]
13 Syriopoulou E, Gasparini A, Humphreys K, Andersson TM. Assessing lead time bias due to mammography screening on estimates of loss in life expectancy. Breast Cancer Res 2022;24:15. [PMID: 35197123 DOI: 10.1186/s13058-022-01505-3] [Reference Citation Analysis]
14 Smith MJ, Belot A, Quartagno M, Luque Fernandez MA, Bonaventure A, Gachau S, Benitez Majano S, Rachet B, Njagi EN. Excess Mortality by Multimorbidity, Socioeconomic, and Healthcare Factors, amongst Patients Diagnosed with Diffuse Large B-Cell or Follicular Lymphoma in England. Cancers (Basel) 2021;13:5805. [PMID: 34830964 DOI: 10.3390/cancers13225805] [Reference Citation Analysis]
15 Smith MJ, Njagi EN, Belot A, Leyrat C, Bonaventure A, Benitez Majano S, Rachet B, Luque Fernandez MA. Association between multimorbidity and socioeconomic deprivation on short-term mortality among patients with diffuse large B-cell or follicular lymphoma in England: a nationwide cohort study. BMJ Open 2021;11:e049087. [PMID: 34848510 DOI: 10.1136/bmjopen-2021-049087] [Reference Citation Analysis]
16 Lee KC, Chung KC, Chen HH, Cheng KC, Wu KL, Song LC, Hu WH. The Impact of Comorbid Diabetes on Short-Term Postoperative Outcomes in Stage I/II Colon Cancer Patients Undergoing Open Colectomy. Biomed Res Int 2020;2020:2716395. [PMID: 32802836 DOI: 10.1155/2020/2716395] [Reference Citation Analysis]
17 Secinti E, Lewson AB, Wu W, Kent EE, Mosher CE. Health-Related Quality of Life: A Comparative Analysis of Caregivers of People With Dementia, Cancer, COPD/Emphysema, and Diabetes and Noncaregivers, 2015-2018 BRFSS. Ann Behav Med 2021;55:1130-43. [PMID: 33761526 DOI: 10.1093/abm/kaab007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Rubio FJ, Alvares D, Redondo-sanchez D, Marcos-gragera R, Sánchez M, Luque-fernandez MA. Bayesian variable selection and survival modeling: assessing the Most important comorbidities that impact lung and colorectal cancer survival in Spain. BMC Med Res Methodol 2022;22. [DOI: 10.1186/s12874-022-01582-0] [Reference Citation Analysis]
19 Swaby J, Kaninjing E, Ogunsanya M. African American participation in cancer clinical trials. Ecancermedicalscience 2021;15:1307. [PMID: 34824630 DOI: 10.3332/ecancer.2021.1307] [Reference Citation Analysis]
20 Smith MJ, Fernandez MAL, Belot A, Quartagno M, Bonaventure A, Majano SB, Rachet B, Njagi EN. Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England. Br J Cancer 2021. [PMID: 34389805 DOI: 10.1038/s41416-021-01523-6] [Reference Citation Analysis]
21 Niksic M, Redondo-Sanchez D, Chang YL, Rodriguez-Barranco M, Exposito-Hernandez J, Marcos-Gragera R, Oliva-Poch E, Bosch-Barrera J, Sanchez MJ, Luque-Fernandez MA. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study. BMC Cancer 2021;21:1048. [PMID: 34556072 DOI: 10.1186/s12885-021-08801-9] [Reference Citation Analysis]
22 Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Grønlie Guren M, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Aagard Thomsen L, Møller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. Int J Cancer 2021;148:1575-85. [PMID: 33006395 DOI: 10.1002/ijc.33326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Tsitkanou S, Murach KA, Washington TA, Greene NP. Exercise Counteracts the Deleterious Effects of Cancer Cachexia. Cancers 2022;14:2512. [DOI: 10.3390/cancers14102512] [Reference Citation Analysis]
24 Ali AE, Elsherbiny DM, Azab SS, El-Demerdash E. The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: Behavioral and mechanistic study. Neurotoxicology 2021;88:1-13. [PMID: 34656704 DOI: 10.1016/j.neuro.2021.10.002] [Reference Citation Analysis]
25 Koné AP, Scharf D. Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study. BMC Cancer 2021;21:406. [PMID: 33853565 DOI: 10.1186/s12885-021-08102-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Koo MM, Swann R, McPhail S, Abel GA, Renzi C, Rubin GP, Lyratzopoulos G. The prevalence of chronic conditions in patients diagnosed with one of 29 common and rarer cancers: A cross-sectional study using primary care data. Cancer Epidemiol 2020;69:101845. [PMID: 33227628 DOI: 10.1016/j.canep.2020.101845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Dibble KE, Kaur M, Lyu J, Connor AE. Evaluation of health perceptions and healthcare utilization among population-based female cancer survivors and cancer-free women. Cancer Causes Control 2021. [PMID: 34613541 DOI: 10.1007/s10552-021-01498-y] [Reference Citation Analysis]
28 Strang P, Hedman C, Adlitzer H, Schultz T. Dying from cancer with COVID-19: age, sex, socio-economic status, and comorbidities. Acta Oncol 2021;60:1019-24. [PMID: 34101521 DOI: 10.1080/0284186X.2021.1934536] [Reference Citation Analysis]
29 Lorimer CF, Simcock R. Multimorbidity and Cancer: the Patient as a Whole Being. Clin Oncol (R Coll Radiol) 2020;32:549-50. [PMID: 32684504 DOI: 10.1016/j.clon.2020.06.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Koczwara B, Deckx L, Ullah S, van den Akker M. Impact of comorbidities on physical function and survival of middle-aged, as compared to older, individuals with cancer. Support Care Cancer 2021. [PMID: 34553253 DOI: 10.1007/s00520-021-06567-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ashley L, Kassim S, Kellar I, Kidd L, Mair F, Matthews M, Price M, Swinson D, Taylor J, Velikova G, Wadsley J. Identifying ways to improve diabetes management during cancer treatments (INDICATE): protocol for a qualitative interview study with patients and clinicians. BMJ Open 2022;12:e060402. [PMID: 35193924 DOI: 10.1136/bmjopen-2021-060402] [Reference Citation Analysis]
32 Garrison DA, Talebi Z, Eisenmann ED, Sparreboom A, Baker SD. Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors. Pharmaceutics 2020;12:E856. [PMID: 32916864 DOI: 10.3390/pharmaceutics12090856] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
33 Higashi T. Cancer epidemiology and treatment patterns for older persons in Japan: a review of nationwide data and statistics. Jpn J Clin Oncol 2022:hyac011. [PMID: 35149875 DOI: 10.1093/jjco/hyac011] [Reference Citation Analysis]
34 Kim K, Xu W, Hong SJ, Starkweather A, Brown RF, Walsh S. Perceived discrimination and physical activity mediate the associations between receiving a survivorship care plan and cancer pain. Cancer Epidemiology 2022;78:102155. [DOI: 10.1016/j.canep.2022.102155] [Reference Citation Analysis]